TCM product approved for sale in Singapore

2020-05-07 Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus

Information on Lianhua Qingwen capsules on the website of Health Sciences Authority of Singapore. (Photo provided to

Lianhua Qingwen, a recommended medicine for treating patients with mild COVID-19 symptoms, has been approved as a Chinese proprietary medicine by the Health Sciences Authority in Singapore.

The designation means the product can be sold in the country as a medicine, the drug's manufacturer said on Wednesday.

Made by Shijiazhuang Yiling Pharmaceutical Co, in Shijiazhuang, Hebei province, the medicine meets Singapore's standards for registration as a Chinese patent medicine, it said.

The capsule, a traditional Chinese medicine used in the treatment of influenza, has been approved for sale as a medicine, food supplement or natural health product in a dozen countries and regions, including Brazil, Romania, Thailand and Ecuador. It can also be sold in the Hong Kong and Macao special administrative regions.


Most popular in 24h

MoreTop news


Back to top Links | About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2020 All rights reserved.
Reproduction in whole or in part without permission is prohibited.